Fidelity Advisor Health Care Fund Class M
FACTX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 245 Summer Street Boston MA United States of America 2210
- IPO Date
- Aug 30, 1996
- CIK
- 0000315700
- Website
- fundresearch.fidelity.com
- Similar Companies
- Business
- Fidelity Advisor Health Care Fund Class M (FACTX) is an actively managed open-end mutual fund that seeks capital appreciation by investing primarily in the common stocks of companies engaged in the health care sector. The fund allocates assets across pharmaceuticals; biotechnology; health care equipment and supplies; health care providers and services; life sciences tools and services; and health care technology, with a focus on companies demonstrating strong fundamentals, growth potential, and attractive valuations. It may also invest in other securities, such as preferred stocks, debt obligations, and derivatives, while maintaining a non-diversified portfolio concentrated in health care-related industries. Offered through Fidelity Investments, which serves as investment adviser, the fund is part of the Fidelity Advisor Funds family available to retail investors through financial intermediaries; it features multiple share classes with varying expense ratios and minimum investments, targeting individual investors, financial advisors, and institutions seeking sector-specific exposure. Headquartered in Boston, Massachusetts, Fidelity Investments traces its origins to 1946 and operates globally, managing trillions in assets across mutual funds, ETFs, retirement services, brokerage, and wealth management. The fund's portfolio is benchmarked against the MSCI U.S. Investable Market Health Care 25/50 Index. In recent developments as of late 2025, the fund has benefited from Fidelity Investments' strategic enhancements in active management capabilities, including the integration of advanced AI-driven analytics for health care stock selection amid sector volatility from regulatory changes and innovation cycles; notable portfolio adjustments include increased allocations to biotechnology firms advancing gene therapies and AI-enabled diagnostics. Fidelity announced expansions in its health care-focused offerings in 2024, launching complementary ESG-screened variants and partnering with leading health tech accelerators to identify early-stage opportunities. No major reorganizations or name changes have occurred within the past two years, though ongoing operational shifts emphasize sustainable investing themes within the sector.